Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 147 Pages
Report ld: 6502378
Request Sample
Customized Report
The global Modafinil API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Modafinil API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Modafinil API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Modafinil API. The Modafinil API market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Modafinil API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Modafinil API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Modafinil API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Modafinil API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Modafinil API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Modafinil API Market Overview
1.1 Product Definition
1.2 Modafinil API by Type
1.2.1 Global Modafinil API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Modafinil API by Application
1.3.1 Global Modafinil API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Modafinil API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Modafinil API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Modafinil API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Modafinil API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Modafinil API Production Market Share by Manufacturers (2021–2026)
2.2 Global Modafinil API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Modafinil API, Industry Ranking, 2024 vs 2025
2.4 Global Modafinil API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Modafinil API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Modafinil API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Modafinil API, Product Offerings and Applications
2.8 Global Key Manufacturers of Modafinil API, Date of Entry into the Industry
2.9 Modafinil API Market Competitive Situation and Trends
2.9.1 Modafinil API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Modafinil API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Modafinil API Production by Region
3.1 Global Modafinil API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Modafinil API Production Value by Region (2021–2032)
3.2.1 Global Modafinil API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Modafinil API by Region (2027–2032)
3.3 Global Modafinil API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Modafinil API Production Volume by Region (2021–2032)
3.4.1 Global Modafinil API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Modafinil API by Region (2027–2032)
3.5 Global Modafinil API Market Price Analysis by Region (2021–2032)
3.6 Global Modafinil API Production, Value, and Year-over-Year Growth
3.6.1 North America Modafinil API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Modafinil API Production Value Estimates and Forecasts (2021–2032)
3.6.3 India Modafinil API Production Value Estimates and Forecasts (2021–2032)
3.6.4 Israel Modafinil API Production Value Estimates and Forecasts (2021–2032)
4 Modafinil API Consumption by Region
4.1 Global Modafinil API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Modafinil API Consumption by Region (2021–2032)
4.2.1 Global Modafinil API Consumption by Region (2021–2026)
4.2.2 Global Modafinil API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Modafinil API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Modafinil API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Modafinil API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Modafinil API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Modafinil API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Modafinil API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Modafinil API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Modafinil API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Modafinil API Production by Type (2021–2032)
5.1.1 Global Modafinil API Production by Type (2021–2026)
5.1.2 Global Modafinil API Production by Type (2027–2032)
5.1.3 Global Modafinil API Production Market Share by Type (2021–2032)
5.2 Global Modafinil API Production Value by Type (2021–2032)
5.2.1 Global Modafinil API Production Value by Type (2021–2026)
5.2.2 Global Modafinil API Production Value by Type (2027–2032)
5.2.3 Global Modafinil API Production Value Market Share by Type (2021–2032)
5.3 Global Modafinil API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Modafinil API Production by Application (2021–2032)
6.1.1 Global Modafinil API Production by Application (2021–2026)
6.1.2 Global Modafinil API Production by Application (2027–2032)
6.1.3 Global Modafinil API Production Market Share by Application (2021–2032)
6.2 Global Modafinil API Production Value by Application (2021–2032)
6.2.1 Global Modafinil API Production Value by Application (2021–2026)
6.2.2 Global Modafinil API Production Value by Application (2027–2032)
6.2.3 Global Modafinil API Production Value Market Share by Application (2021–2032)
6.3 Global Modafinil API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Aurobindo Pharma Limited
7.1.1 Aurobindo Pharma Limited Modafinil API Company Information
7.1.2 Aurobindo Pharma Limited Modafinil API Product Portfolio
7.1.3 Aurobindo Pharma Limited Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Aurobindo Pharma Limited Main Business and Markets Served
7.1.5 Aurobindo Pharma Limited Recent Developments/Updates
7.2 Jai Radhe Sales
7.2.1 Jai Radhe Sales Modafinil API Company Information
7.2.2 Jai Radhe Sales Modafinil API Product Portfolio
7.2.3 Jai Radhe Sales Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Jai Radhe Sales Main Business and Markets Served
7.2.5 Jai Radhe Sales Recent Developments/Updates
7.3 Mylan
7.3.1 Mylan Modafinil API Company Information
7.3.2 Mylan Modafinil API Product Portfolio
7.3.3 Mylan Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Mylan Main Business and Markets Served
7.3.5 Mylan Recent Developments/Updates
7.4 Seqens
7.4.1 Seqens Modafinil API Company Information
7.4.2 Seqens Modafinil API Product Portfolio
7.4.3 Seqens Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Seqens Main Business and Markets Served
7.4.5 Seqens Recent Developments/Updates
7.5 Wavelength
7.5.1 Wavelength Modafinil API Company Information
7.5.2 Wavelength Modafinil API Product Portfolio
7.5.3 Wavelength Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Wavelength Main Business and Markets Served
7.5.5 Wavelength Recent Developments/Updates
7.6 Om Pharmaceutical Industries
7.6.1 Om Pharmaceutical Industries Modafinil API Company Information
7.6.2 Om Pharmaceutical Industries Modafinil API Product Portfolio
7.6.3 Om Pharmaceutical Industries Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Om Pharmaceutical Industries Main Business and Markets Served
7.6.5 Om Pharmaceutical Industries Recent Developments/Updates
7.7 Gangwal Healthcare
7.7.1 Gangwal Healthcare Modafinil API Company Information
7.7.2 Gangwal Healthcare Modafinil API Product Portfolio
7.7.3 Gangwal Healthcare Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Gangwal Healthcare Main Business and Markets Served
7.7.5 Gangwal Healthcare Recent Developments/Updates
7.8 Alembic Pharmaceuticals Limited
7.8.1 Alembic Pharmaceuticals Limited Modafinil API Company Information
7.8.2 Alembic Pharmaceuticals Limited Modafinil API Product Portfolio
7.8.3 Alembic Pharmaceuticals Limited Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Alembic Pharmaceuticals Limited Main Business and Markets Served
7.8.5 Alembic Pharmaceuticals Limited Recent Developments/Updates
7.9 OrBion Pharmaceuticals
7.9.1 OrBion Pharmaceuticals Modafinil API Company Information
7.9.2 OrBion Pharmaceuticals Modafinil API Product Portfolio
7.9.3 OrBion Pharmaceuticals Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 OrBion Pharmaceuticals Main Business and Markets Served
7.9.5 OrBion Pharmaceuticals Recent Developments/Updates
7.10 PROVENTUS LIFE SCIENCES PVT LTD
7.10.1 PROVENTUS LIFE SCIENCES PVT LTD Modafinil API Company Information
7.10.2 PROVENTUS LIFE SCIENCES PVT LTD Modafinil API Product Portfolio
7.10.3 PROVENTUS LIFE SCIENCES PVT LTD Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 PROVENTUS LIFE SCIENCES PVT LTD Main Business and Markets Served
7.10.5 PROVENTUS LIFE SCIENCES PVT LTD Recent Developments/Updates
7.11 RR LIFESCIENCES
7.11.1 RR LIFESCIENCES Modafinil API Company Information
7.11.2 RR LIFESCIENCES Modafinil API Product Portfolio
7.11.3 RR LIFESCIENCES Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 RR LIFESCIENCES Main Business and Markets Served
7.11.5 RR LIFESCIENCES Recent Developments/Updates
7.12 Maithili Life Sciences Private Limited
7.12.1 Maithili Life Sciences Private Limited Modafinil API Company Information
7.12.2 Maithili Life Sciences Private Limited Modafinil API Product Portfolio
7.12.3 Maithili Life Sciences Private Limited Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Maithili Life Sciences Private Limited Main Business and Markets Served
7.12.5 Maithili Life Sciences Private Limited Recent Developments/Updates
7.13 Gokulendu Life Science
7.13.1 Gokulendu Life Science Modafinil API Company Information
7.13.2 Gokulendu Life Science Modafinil API Product Portfolio
7.13.3 Gokulendu Life Science Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Gokulendu Life Science Main Business and Markets Served
7.13.5 Gokulendu Life Science Recent Developments/Updates
7.14 Gangwal Chemicals
7.14.1 Gangwal Chemicals Modafinil API Company Information
7.14.2 Gangwal Chemicals Modafinil API Product Portfolio
7.14.3 Gangwal Chemicals Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Gangwal Chemicals Main Business and Markets Served
7.14.5 Gangwal Chemicals Recent Developments/Updates
7.15 Bo-Chem Pvt Ltd
7.15.1 Bo-Chem Pvt Ltd Modafinil API Company Information
7.15.2 Bo-Chem Pvt Ltd Modafinil API Product Portfolio
7.15.3 Bo-Chem Pvt Ltd Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Bo-Chem Pvt Ltd Main Business and Markets Served
7.15.5 Bo-Chem Pvt Ltd Recent Developments/Updates
7.16 ZCL Chemicals Limited
7.16.1 ZCL Chemicals Limited Modafinil API Company Information
7.16.2 ZCL Chemicals Limited Modafinil API Product Portfolio
7.16.3 ZCL Chemicals Limited Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 ZCL Chemicals Limited Main Business and Markets Served
7.16.5 ZCL Chemicals Limited Recent Developments/Updates
7.17 Nishchem International Pvt. Ltd
7.17.1 Nishchem International Pvt. Ltd Modafinil API Company Information
7.17.2 Nishchem International Pvt. Ltd Modafinil API Product Portfolio
7.17.3 Nishchem International Pvt. Ltd Modafinil API Production, Value, Price, and Gross Margin (2021–2026)
7.17.4 Nishchem International Pvt. Ltd Main Business and Markets Served
7.17.5 Nishchem International Pvt. Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Modafinil API Industry Chain Analysis
8.2 Modafinil API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Modafinil API Production Modes and Processes
8.4 Modafinil API Sales and Marketing
8.4.1 Modafinil API Sales Channels
8.4.2 Modafinil API Distributors
8.5 Modafinil API Customer Analysis
9 Modafinil API Market Dynamics
9.1 Modafinil API Industry Trends
9.2 Modafinil API Market Drivers
9.3 Modafinil API Market Challenges
9.4 Modafinil API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Modafinil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 149
USD 3950.00
(Single User License)
The global Modafinil API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 109
USD 4250.00
(Single User License)
The global Modafinil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 173
USD 4900.00
(Single User License)
The global market for Modafinil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 131
USD 3950.00
(Single User License)
The global market for Modafinil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
Published Date: 2024-02-07
Pages: 115
USD 2900.00
(Single User License)
The global market for Modafinil API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 149
The global Modafinil API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 109
The global Modafinil API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 173
The global market for Modafinil API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 131
The global market for Modafinil API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 110
Modafinil(CAS:68693-11-8) is a central nervous system (CNS) stimulant medication used to treat sleepiness due to narcolepsy, shift work sleep disorder, and obstructive sleep apnea.
Published: 2024-02-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now